RepliCel Life Sciences's total assets for Q4 2025 were C$97.01K, an increase of 610.35% from the previous quarter. REPCF total liabilities were C$5.01M for the fiscal quarter, a 310.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.